Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 71% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money

71% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.

  • Updates
  • biotechnology
  • digital transformation
  • electric vehicles
  • health wellness
  • semiconductors

Top Stories

Samsung tech theft, Glencore backs SPAC, Novartis acquires kidney biopharma

In today’s top stories, shares in Samsung slipped 1% as a former executive was arrested on allegations that they stole data and tech needed to replicate one of its chip factories. Elsewhere, Novartis has announced it’s to acquire biopharma Chinook Therapeutics for $3.2bn. Miner Glencore, Stellantis and Volkswagen’s battery division PowerCo are backing ACG Acquisition Company, a SPAC which is raising $1bn to buy two mines in Brazil. Chinese electric vehicle maker Nio has slashed the prices of all its models by 6–9% as it bids to keep up with domestic rivals. Lastly, Spanish construction firm Sacyr is to offload its waste management unit onto Morgan Stanley Infrastructure Partners.

Novartis boosts kidney portfolio

Swiss drugmaker Novartis [NVS] has announced it’s to acquire biopharma Chinook Therapeutics [KDNY] for $3.2bn, or $40 per share, which represents a 66.7% premium on Friday’s closing price of $23.99. The buyout would see Novartis boost its renal pipeline with two late-stage programmes targeting kidney disease. Big pharma and biotech companies spent $85bn on M&A in the first five months of the year, according to a Financial Times report.

Glencore backs Brazilian mine SPAC

SPACs may have lost their shine since the pandemic, but miner Glencore [GLEN.L], Stellantis [STLA] and Volkswagen’s [VOW.DE] battery division PowerCo are backing ACG Acquisition Company, which is raising $1bn to buy two mines in Brazil. Once finalised, the blank cheque vehicle will become ACG Electric Metals and 49% of the shares will be available free float, reported Reuters. Elsewhere, Glencore has approached Canadian miner Teck Resources [TECK] about buying its coal business.

Nio ends battery-swapping programme

Chinese electric vehicle (EV) maker Nio [NIO] has slashed the prices of all its models by 6–9% as it bids to keep up with domestic rivals, namely BYD [1211.HK] and XPeng [XPEV]. The company has also called time on its free battery-swapping programme for all buyers placing deposits from yesterday. “The adjustments had been discussed internally for quite a while,” Nio CEO William Li said in a statement, adding that he’s aware that “we can’t make everyone happy”.

Ex-Samsung exec accused of data theft

Shares in Samsung Electronics [005935.KS] slipped 1% as a former executive was arrested Monday on allegations that they stole data and tech needed to replicate one of its chip factories. The breach is so severe, “it’s difficult to compare with… previous individual semiconductor technology leakage cases,” Suwon District Prosecutors Office in South Korea was quoted as saying by Bloomberg. Taiwan’s chip exports to the US grew for the 26th consecutive month in May.

Sacyr to sell waste management unit

Spanish construction firm Sacyr [SCYR.MC] is to offload its waste management unit onto Morgan Stanley Infrastructure Partners. According to Reuters, the deal values the unit, Valoriza Servicios Medioambientales, at €734m and is part of Sacyr’s plan to reduce its debt pile and shift focus to its public–private partnership business. Sacyr’ s shares were up 2.1% at lunchtime.

Disclaimer Past performance is not a reliable indicator of future results.

CMC Markets is an execution-only service provider. The material (whether or not it states any opinions) is for general information purposes only, and does not take into account your personal circumstances or objectives. Nothing in this material is (or should be considered to be) financial, investment or other advice on which reliance should be placed. No opinion given in the material constitutes a recommendation by CMC Markets or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person.

The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although we are not specifically prevented from dealing before providing this material, we do not seek to take advantage of the material prior to its dissemination.

CMC Markets does not endorse or offer opinion on the trading strategies used by the author. Their trading strategies do not guarantee any return and CMC Markets shall not be held responsible for any loss that you may incur, either directly or indirectly, arising from any investment based on any information contained herein.

*Tax treatment depends on individual circumstances and can change or may differ in a jurisdiction other than the UK.

Continue reading for FREE

Latest articles